Development and Validation of an Oral Fluid LC–MS/MS Method for Screening Emerging Synthetic Opioids Including Fentanyl Analogues, Nitazenes, and Xylazine

Clicks: 14
ID: 333820
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #62 of 68 articles by views in journal of analytical toxicology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The emergence of highly potent synthetic opioids, including fentanyl analogues, nitazenes, and xylazine-associated drug mixtures, has created significant analytical challenges for forensic and toxicological laboratories. The aim of this study was to develop and validate a qualitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the screening of emerging synthetic opioids in oral fluid. Sample preparation was based on direct extraction of paper swabs with 500 μL of methanol containing 1% formic acid, followed by vortex mixing, ultrasonication, centrifugation, and direct LC-MS/MS analysis without evaporation or reconstitution. Method validation included selectivity and specificity, detection capability, matrix effects, inter-individual matrix variability, processed-sample stability, carryover, and intra-day precision. All target analytes fulfilled the established identification criteria at 1 ng/mL, the lowest concentration evaluated. Intra-day precision was acceptable, with RSD values ranging from 0.6% to 14.8%. Matrix effects were within 80-120% for the majority of analytes at both evaluated concentration levels, although compound-dependent ion suppression or enhancement was observed. Processed samples met the predefined stability criterion for 48 h at 4 °C and 72 h at - 20 °C, and carryover remained below the predefined acceptance criterion. Limited inter-individual variability was observed among the five donor matrices for the subset of analytes evaluated. The developed method provides a simple qualitative screening approach for an expanded panel of emerging synthetic opioids in oral fluid. Evaluation using authentic positive specimens is required to further establish its performance in forensic and DUID applications.
Reference Key
openalex_W7223456112 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chara Parpala, Sotirios Toskos, Christina Matiaki, Evdokia Brousa, Heleni Zaggelidou, Νikolaos Raikos, Orthodoxia Mastrogianni
Are you one of these authors? Claim your profile
Journal journal of analytical toxicology
Year 2026
DOI
10.1093/jat/bkag091
URL
https://academic.oup.com/jat/advance-article-pdf/doi/10.1093/jat/bkag091/72452750/bkag091.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.